Riemelt Abel
Department of Urology, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany
Potente Kruger
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16–18, 04107, Leipzig, Germany
ABSTRACT
With the emergence of personalised medicine, healthcare has undergone a radical change as treatment plans are now based on a patient's unique genetics, lifestyle, and environment. This paradigm change has significant ramifications for many areas of healthcare, including the creation of tailored treatments and cutting-edge diagnostics, as well as patient empowerment over healthcare choices. Through the use of genomics, personalised medicine can identify genetic markers linked to certain diseases. Due to this knowledge, healthcare professionals may now prescribe less harmful and more successful therapies, especially in cancer therapy. Furthermore, improved medication responses and more precise diagnoses are made possible by the research of pharmacogenomics and sophisticated diagnostic instruments. Treatment is not the only effect; preventative measures based on a person's genetic predispositions also have an influence. Knowing their health risks gives patients the power to take charge of their treatment, actively participate in conversations with medical professionals, and make well-informed decisions. Personalised treatment has a significant potential for long-term cost-effectiveness, notwithstanding possible upfront expenses. It can optimise healthcare resource utilisation by lowering adverse responses, hospital readmissions, and ineffective therapies. Personalised medicine will continue to impact medication development and research, resulting in more focused and effective methods. Technology and stakeholder collaboration innovations could further mould healthcare into a more customised, efficient, and patient-focused approach. The summary succinctly captures how personalised medicine is revolutionising healthcare and its broad implications in the future.
Keywords: Advancement (AA), Molecular Diagnostics (MD), Personalized Medicine (PM),.
